Refine
Document Type
- Article (2)
- Doctoral Thesis (1)
- Postprint (1)
Is part of the Bibliography
- yes (4) (remove)
Keywords
- bulimia nervosa (4) (remove)
Institute
Background: Compulsive exercise (CE) is a frequent symptom in patients with eating disorders (EDs). It includes, in addition to quantitatively excessive exercise behaviour, a driven aspect and specific motives of exercise. CE is generally associated with worse therapy outcomes. The aims of the study were to compare self-reported quantity of exercise, compulsiveness of exercise as well as motives for exercise between patients with anorexia nervosa (AN), bulimia nervosa (BN) and healthy controls (HC). Additionally, we wanted to explore predictors of compulsive exercise (CE) in each group.
Methods: We investigated 335 female participants (n = 226 inpatients, n = 109 HC) and assessed self-reported quantity of exercise, compulsiveness of exercise (Compulsive Exercise Test), motives for exercise (Exercise Motivations Inventory-2), ED symptoms (Eating Disorder Inventory-2), obsessive-compulsiveness (Obsessive-Compulsive Inventory-Revised), general psychopathology (Brief Symptom Inventory-18) and depression (Beck Depression Inventory-2).
Results: Both patients with AN and BN exercised significantly more hours per week and showed significantly higher CE than HC; no differences were found between patients with AN and BN. Patients with EDs and HC also partly varied in motives for exercise. Specific motives were enjoyment, challenge, recognition and weight management in patients with EDs in contrast to ill-health avoidance and affiliation in HC. Patients with AN and BN only differed in regard to exercise for appearance reasons in which patients with BN scored higher. The most relevant predictor of CE across groups was exercise for weight and shape reasons.
Conclusions: Exercise behaviours and motives differ between patients with EDs and HC. CE was pronounced in both patients with AN and BN. Therefore, future research should focus not only on CE in patients with AN, but also on CE in patients with BN. Similarities in CE in patients with AN and BN support a transdiagnostic approach during the development of interventions specifically targeting CE in patients with EDs.
Background: Empirical evidence suggests substantial deficits regarding emotion recognition in bulimia nervosa (BN). The aim of the current study was to investigate electrophysiologic evidence for deficits in emotional face processing in patients with BN. Methods: Event-related potentials were recorded from 13 women with BN and 13 matched healthy controls while viewing neutral, happy, fearful, and angry facial expressions. Participants' recognition performance for emotional faces was tested in a subsequent categorization task. In addition, the degree of alexithymia, depression, and anxiety were assessed via questionnaires. Results: Categorization of emotional faces was hampered in BN (p = .01). Amplitudes of event-related potentials differed during emotional face processing: face-specific N170 amplitudes were less pronounced for angry faces in patients with BN (mean [M] [standard deviation {SD}] = 1.46 [0.56] mu V versus M [SD] = -1.23 [0.61] mu V, p = .02). In contrast, P3 amplitudes were more pronounced in patients with BN as compared with controls (M [SD] = 2.64 [0.46] mu V versus M [SD] = 1.25 [0.39] mu V, p = .04), independent of emotional expression. Conclusions: The study provides novel electrophysiologic data showing that emotional faces are processed differently in patients with BN as compared with healthy controls. We suggest that deficits in early automatic emotion classification in BN are followed by an increased allocation of attentional resources to compensate for those deficits. These findings might contribute to a better understanding of the impaired social functioning in BN.
Das Ziel der Doktorarbeit war die Entwicklung und Evaluation eines skillsbasierten primären Präventionsprogramms (Mainzer Schultraining zur Essstörungsprävention (MaiStep)) für partielle und manifeste Essstörungen. Dabei wurde die Wirksamkeit durch einen primären (Reduktion vorhandener Essstörungssymptome) und sekundären (assoziierte Psychopathologie) Zielparameter 3 und 12 Monate nach Durchführung des Trainings überprüft. Innerhalb der randomisiert kontrollierten Studie gab es zwei Interventionsgruppe und eine aktive Kontrollgruppe. 1.654 Jugendliche (weiblich/männlich: 781/873; mittleres Alter: 13.1±0.7; BMI: 20.0±3.5) konnten für die Studie, an zufällig ausgewählten Schulen in Rheinland-Pfalz, rekrutiert werden. Die Entwicklung des Präventionsprogramms basiert auf einem systematischen Literaturreview von 63 wissenschaftlichen Studien über die Prävention von Essstörungen im Kindes- und Jugendalter. Eine Interventionsgruppe wurde durch Psychologinnen/Psychologen und eine zweite durch Lehrkräfte angeleitet. Das in der aktiven Kontrollgruppe durchgeführte Sucht- bzw. Stresspräventionsprogramm wurde durch Lehrkräfte geleitet. MaiStep zeigte zur 3-Monatskatamnese keine signifikanten Effekte im Vergleich zur aktiven Kontrollgruppe. Allerdings zeigten sich nach 12 Monaten multiple signifikante Effekte zwischen den Interventions- und der aktiven Kontrollgruppe. Im Rahmen der Analyse des primären Parameters wurden in den Interventionsgruppen signifikant weniger Jugendliche mit einer partiellen Anorexia nervosa (CHI²(2) = 8.74, p = .01**) und/oder partiellen Bulimia nervosa (CHI²(2) = 7.25, p = .02*) gefunden. Im Rahmen der sekundären Zielparameter zeigten sich signifikante Veränderungen in Subskalen des Eating Disorder Inventory (EDI-2) Schlankheitsstreben (F (2, 355) = 3.94, p = .02*) und Perfektionismus (F (2, 355) = 4.19, p = .01**) sowie dem Body Image Avoidance Questionnaire (BIAQ) (F (2, 525) = 18.79, p = .01**) zwischen den Interventions- und der aktiven Kontrollgruppe. MaiStep kann somit als erfolgreiches Programm zur Reduktion von partiellen Essstörungen für die Altersgruppe der 13- 15-jährigen bezeichnet werden. Trotz unterschiedlicher Wirkmechanismen zeigten sich die Lehrkräfte im Vergleich zu den Psychologinnen/Psychologen ebenso erfolgreich in der Durchführung.
Trial registration MaiStep is registered at the German Clinical Trials Register (DRKS00005050).